EpiVax, Inc. – Trademark Portfolio
Entity Type: 03
EpiVax, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include ANCER, PANDA, EPIVAX, PREDEFT, and EPIMATRIX. The owner is based in Providence, RI.
146 Clifford Street
Providence, RI 02903
Showing of trademarks Trademarks
Trademark Classifications
EpiVax, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does EpiVax, Inc. have?
EpiVax, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 8 registered, 2 abandoned, 2 cancelled.
What trademark classes does EpiVax, Inc. file in?
EpiVax, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are EpiVax, Inc.'s most well-known trademarks?
EpiVax, Inc.'s registered trademark portfolio includes well-known marks such as ANCER, PANDA, EPIVAX, PREDEFT, and EPIMATRIX. These are among 8 currently registered trademarks in the portfolio.
What is EpiVax, Inc.'s trademark registration success rate?
EpiVax, Inc. has a 67% trademark registration rate, with 8 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.